Anavex Life Sciences Corp (NASDAQ:AVXL)

17.52
BATS BZX Real-Time Price
As of Oct 15
 0.00 / 0.00%
Today’s Change
4.51
Today|||52-Week Range
31.50
+224.44%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2018
Quarter 4
2018
Quarter 1
2019
Quarter 2
2019
Operating ActivitiesNet Income / Starting Line-5.8M-7.3M-8.0M-7.1M
 
 
 
 
 
Total Other Cash Flow1.5M2.0M1.9M1.3M
 
 
 
 
 
Funds From Operations-4.3M-5.3M-6.1M-5.8M
 
 
 
 
 
Funds From/For Other Operating Expenses-248.3K-1.1M-1.8M1.6M
 
 
 
 
 
Net Cash Flow - Operating Activities-4.1M-4.2M-4.4M-7.4M
 
 
 
 
 
 
InvestingNet Cash Flow Investing0.000.000.000.00--
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings0.000.000.000.00--
Long Term Debt Reduction0.000.000.000.00--
Net Proceeds Stock Sale1.2M2.0M3.1M9.3M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends----------
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing101.1K0.000.0050.0K
 
 
 
Net Cash Flow - Financing1.2M2.0M3.1M9.2M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash----------
 
Net Change In Cash-2.9M-2.2M-1.3M1.8M